Nivolumab is already approved for use in cases of melanoma, renal cancer, Hodgkin lymphoma and a form of cancer affecting the head and neck, and has now been approved for lung cancer.

The Health Service Executive (HSE) has recommended the use of the potentially life-extending cancer drug nivolumab (sold as Opdivo) for patients with (...)

Cancer Week Ireland runs from Monday, September 25th to Sunday, October 1st

Everyone knows someone who has been affected by cancer – whether as a patient or a carer. And as latest statistics show that one in three of us may de(...)